A new study published in Plastic and Reconstructive Surgery has suggested that intradermal botulinum toxin injection, or microbotulinum, is a safe and effective method to treat skin flaws.
Global pharmaceutical company Allergan and biopharmaceutical company Paratek have confirmed that two phase 3 trials of sarecycline met their 12-week primary efficacy endpoints.
Dalvi Humzah Aesthetic Training (DHAT) has launched an online version of its cannula training course.
A new marketing study has indicated a high level of patient satisfaction following lip enhancements.
Pharmaceutical company Sinclair Pharma has launched a new bio-stimulating dermal filler for the body.
To accompany the launch of new dermal filler Kysense, aesthetic company Circa Skin will host a webinar discussing its technology and techniques.
The Scottish Government has proposed a new legislation for the aesthetics industry which could see non-medical practitioners requiring a license in order to perform injectable treatments.
Research published in Scientific Reports journal has suggested that botulinum toxin (BoNT-A) could be used as an effective treatment for patients with depression.
Medical aesthetic company Intraline has released three new dermal fillers to its M Series line, the M2 Plus, the M3 Plus and M4 Plus.
A new drug has been developed that aims to mimic sunlight and cause the skin to tan without the damaging effects of UV radiation.